EVEBRA device
DeviceWear 2 weeks pre-operatively for a total duration of 200 hours. Wear 2 weeks post-operatively for 10 hours a day.
NCT Number: NCT05003635
This multicentre randomized controlled trial aims to evaluate a new breast reconstruction technique- autologous fat transfer (AFT). Female patients with breast cancer schedule to receive a mastectomy (or having undergone mastectomy in the past) will be randomized to undergo breast reconstruction with either AFT with the EVEBRA device(intervention group) or AFT without the EVEBRA device (control group). AFT will be evaluated in terms of volume, quality of life, aesthetic result, complications and oncological safety.
Interested in participating?
Request Info23 year–69 year
Female
Interventional
Not applicable
Maastricht University Medical Center+, Maastricht, Limburg, Netherlands
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Wear 2 weeks pre-operatively for a total duration of 200 hours. Wear 2 weeks post-operatively for 10 hours a day.
Time frame: 1 year
All women will have an MRI for Baseline Breast Volume measurement at the time of enrollment. Final breast volume will be also determined by MRI 6 months after the first grafting procedure (AFT#1).
The primary effectiveness endpoint is the Percentage Augmentation of the mastectomy defect at 12 months after AFT#1.
Time frame: 12 months
Presence + description of necrotic cysts (Scale: amount of cyst and size in centimeters)
Time frame: 12 months
Qscore will be used to assess final scores. As described in the BREAST-Q Module, summed scores will be converted into a score from 0 (worst) to 100 (best) per domain. Higher scores reflect a better outcome.
Time frame: 12 months
Time frame: 12 months
The aesthetic improvement will be rated using pre-operative and one year post-operative 2D images by a group of experts, breast cancer patients and age-matched male and female laymen. All parties rate the pre-/post- 3D images on a Likert scale (5 points) with one indicating no improvement and 5 indicating perfect improvement.
Time frame: 12 months
Difference noted in centimeters (cm)
Time frame: 12 months
Cup size before and after reconstruction will be noted .
Time frame: 12 months
Volume change will be noted in cubic centimetre(cc)
Contact information is provided by the study sponsor or research team.
Maastricht University Medical Center
Other
External Vacuum Expansion: Evaluation in Breast Reconstructive Surgery
Acronym: EVE
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05535192
Breast Cancer, Breast Cancer Female
Boston, Massachusetts, United States
View Trial DetailsNCT06507618
Breast Cancer Female, Breast Diseases
New Haven, Connecticut, United States
View Trial DetailsNCT05982496
Adenocarcinoma, Axillary Lymphadenopathy
Milan, MI, Italy
View Trial DetailsNCT07198724
Breast Cancer, Breast Cancer Female
Boston, Massachusetts, United States
View Trial Details